<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hong EP</submitter><funding>Hallym University</funding><pagination>6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7824099</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>Personalized risk prediction for diabetic cardiovascular disease (DCVD) is at the core of precision medicine in type 2 diabetes (T2D). We first identified three marker sets consisting of 15, 47, and 231 tagging single nucleotide polymorphisms (tSNPs) associated with DCVD using a linear mixed model in 2378 T2D patients obtained from four population-based Korean cohorts. Using the genetic variants with even modest effects on phenotypic variance, we observed improved risk stratification accuracy beyond traditional risk factors (AUC, 0.63 to 0.97). With a cutoff point of 0.21, the discrete genetic liability threshold model consisting of 231 SNPs (GLT&lt;sub>231&lt;/sub>) correctly classified 87.7% of 2378 T2D patients as high or low risk of DCVD. For the same set of SNP markers, the GLT and polygeni</pubmed_abstract><journal>Metabolites</journal><pubmed_title>The Liability Threshold Model for Predicting the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Multi-Cohort Study of Korean Adults.</pubmed_title><pmcid>PMC7824099</pmcid><funding_grant_id>HRF-201711-015</funding_grant_id><pubmed_authors>Hong EP</pubmed_authors><pubmed_authors>Park JW</pubmed_authors><pubmed_authors>Heo SG</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Liability Threshold Model for Predicting the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Multi-Cohort Study of Korean Adults.</name><description>Personalized risk prediction for diabetic cardiovascular disease (DCVD) is at the core of precision medicine in type 2 diabetes (T2D). We first identified three marker sets consisting of 15, 47, and 231 tagging single nucleotide polymorphisms (tSNPs) associated with DCVD using a linear mixed model in 2378 T2D patients obtained from four population-based Korean cohorts. Using the genetic variants with even modest effects on phenotypic variance, we observed improved risk stratification accuracy beyond traditional risk factors (AUC, 0.63 to 0.97). With a cutoff point of 0.21, the discrete genetic liability threshold model consisting of 231 SNPs (GLT&lt;sub>231&lt;/sub>) correctly classified 87.7% of 2378 T2D patients as high or low risk of DCVD. For the same set of SNP markers, the GLT and polygeni</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2026-04-29T21:27:26.918Z</modification><creation>2021-02-21T03:01:30Z</creation></dates><accession>S-EPMC7824099</accession><cross_references><pubmed>33374401</pubmed><doi>10.3390/metabo11010006</doi></cross_references></HashMap>